Loading stock data…
MRK.DE
€109.45-2.45 (-2.19%)
Market OpenUpdated 10:14 AM EDT
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Merck KGaA in the Healthcare sector is trading at €109.60. The stock is currently 17% below its 52-week high of €131.65, remaining 3.1% below its 200-day moving average. Technical signals show neutral RSI of 59 and bullish MACD crossover, explaining why MRK.DE maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 59) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price€109.45
Potential Upside
2.7%
Whystock Fair Value€112.39
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Buy
Mean target€141.27+29.1%
Range€112.00 – €179.00
Fundamentals
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
€50.26B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.27
Beta
Defensive asset. Lower volatility than the S&P 500.
0.80
Div Yield
Strong income play. Yield provides a meaningful total return floor.
187.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.92%
Volume
Today's trading volume
70,656
Recent News
Sanofi Posts Higher Sales Amid Leadership Transition
Sales rose 14% to €10.51 billion at constant currency, boosted by new launches and recent acquisitions.
Here's What We Like About Merck KGaA's (ETR:MRK) Upcoming Dividend
It looks like Merck KGaA ( ETR:MRK ) is about to go ex-dividend in the next three days. The ex-dividend date is...
Assessing Merck KGaA (XTRA:MRK) Valuation After Mixed Recent Share Performance And Healthcare Pipeline Developments
Recent performance and business mix Merck KGaA (XTRA:MRK) has drawn investor attention after a mixed share performance, with an 8.3% gain over the past month set against a 9.1% decline over the past 3 months. The company operates across three main segments: Healthcare, Life Science, and Electronics. Healthcare and Life Science generate most of its €21,102m revenue, with Electronics contributing a smaller but meaningful share. Recent annual figures show revenue of €21,102m and net income of...
Merck KGaA acquires JSR chromatography business
The acquisition will add Belgium-based chromatography operations and a team of over 50 employees to Merck.
Analyst Initiates Sanofi (SNY) with ‘Outperform’ Rating
Sanofi (NASDAQ:SNY) is included among the 15 Large Cap Stocks with Highest Dividends. Sanofi (NASDAQ:SNY) is a healthcare biopharmaceutical company that engages in the research, development, manufacture, and marketing of therapeutic solutions. On March 19, Bernstein analyst Justin Smith initiated coverage of Sanofi (NASDAQ:SNY) with an ‘Outperform’ rating and a price target of €110. The […]